Texas abortion ruling's broader implications for FDA drug approval
RECENT NEWS
Countries Not Paying Their Fair Share of the Cost of Biopharmaceutical Innovation - What Can the US Do to Change That?
The principal reason for the disparity in biopharmaceutical pricing is that governments in other developed countries use ... Read more
The coronavirus could help pharma reset its reputation in Washington
The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more
The biggest challenge facing the FDA’s new Rare Disease Innovation Hub
Differing philosophies within and outside of government could doom the hub... Read more